Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease-Reference-Cited by-同舟云学术

Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease

Published:1999-03-02 Issue:5 Volume:96 Page:2279-2284
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Misko I. S.,Cross S. M.,Khanna R.,Elliott S. L.,Schmidt C.,Pye S. J.,Silins S. L.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference53 articles.

1. A novel form of Epstein-Barr virus latency in normal B cells in vivo

2. Strict Lymphotropism of Epstein-Barr Virus During Acute Infectious Mononucleosis in Nonimmunocompromised Individuals

3. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.

4. EPSTEIN-BARR VIRUS ASSOCIATED B-CELL LYMPHOMAS IN AIDS AND AFTER ORGAN TRANSPLANTATION

5. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity;The EMBO Journal;2023-03-13

2. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study;Rheumatology International;2022-06-01

3. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation;Pathogens;2021-06-17

4. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery;Autoimmunity Reviews;2020-10

5. Possible Cross-Reactivity between SARS-CoV-2 Proteins, CRM197 and Proteins in Pneumococcal Vaccines May Protect Against Symptomatic SARS-CoV-2 Disease and Death;Vaccines;2020-09-24